Weekly cisplatin ± glutathione in relapsed ovarian carcinoma
- 1 March 1995
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 5 (2) , 81-86
- https://doi.org/10.1046/j.1525-1438.1995.05020081.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancerAnnals of Oncology, 1993
- Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensityCancer, 1992
- Neurotoxic side-effects of cisplatinEuropean Journal of Cancer and Clinical Oncology, 1991
- Cisplatin induced neuropathy: Central, peripheral and autonomic nerve involvementJournal of Neuro-Oncology, 1990
- Prospective nerve conduction studies in cisplatin therapyAnnals of Neurology, 1988
- Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.Journal of Clinical Oncology, 1987
- Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.Journal of Clinical Oncology, 1986
- High-dose cisplatin in hypertonic saline in refractory ovarian cancer.Journal of Clinical Oncology, 1985
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985